Dr. Richard Smith gave a platform presentation entitled "Computer Assessment of Speech in a Successful ALS Treatment Trial" at the 2018 annual Northeast ALS Consortium (NEALS) meeting in Clearwater Beach, Florida. Subsequently, Dr. Eric Macklin, a collaborator from Harvard University, presented a poster discussing the short-form version of the CNS-BFS, a patient reported outcome for assessing bulbar function in ALS developed by the Center for Neurologic Study. Both of these presentations supplemented work recently published in the following journals: Neurotherapeutics, European Journal of Neurology, and recently, the Journal of Clinical Pharmacology. These studies were initially supported by the ALS award granted by the ALS Association, granted to Dr. Smith.
Publication of Additional Evidence for a Therapeutic Effect of Dextromethorphan/Quinidine on Bulbar Motor Function in Patients with Amyotrophic Lateral Sclerosis: A Quantitative Speech Analysis in the British Journal of Neurology.